
Citihigh P 500mg/800mg Tablet
Marketer
Indoscot Healthcare LLP
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citihigh P 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets are prescribed for stroke recovery and cognitive enhancement. This medication safeguards brain cells from injury and promotes their repair, finding application also in brain trauma management. NeuroMend 500mg/800mg tablets can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's instructions precisely regarding dosage and duration. Missed doses should be taken promptly upon recollection. Complete the prescribed course, even if symptoms improve. Abrupt cessation should be avoided without consulting your doctor to prevent symptom exacerbation. Potential side effects, such as heightened activity, abdominal discomfort, anxiety, and low blood pressure, are generally transient and self-limiting. Persistent or bothersome side effects warrant medical attention. Maintain adequate hydration due to potential diarrhea. Weight gain is possible; a balanced diet and exercise regimen can help mitigate this.
Primary Ingredients of Citihigh P 500mg/800mg Tablet
No text provided to rephrase.
Uses of Citihigh P 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Citihigh P 500mg/800mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citihigh P 500mg/800mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Citihigh P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citihigh P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. Citihigh P 500mg/800mg Tablets can be ingested with or without food, although consistent timing is recommended.
How Citihigh P 500mg/800mg Tablet works:
Citicoline/Piracetam 500mg/800mg tablets (e.g., Citihigh P) combine two neuroprotective agents. Citicoline supports neuronal health by promoting cell survival, safeguarding against damage, and enhancing nourishment. Piracetam, a GABAergic compound, offers cerebral and neurological protection against hypoxia while modulating neuronal ion channel activity.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Citihigh P 500mg/800mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citihigh P 500mg/800mg Tablet in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Citihigh P 500mg/800mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Citihigh P 500mg/800mg Tablets, which can induce drowsiness and tremor. Side effects from this medication may impact your capacity to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Citihigh P 500mg/800mg tablets, as dose modification may be necessary. Individuals with severe kidney disease should avoid this medication altogether. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Citihigh P 500mg/800mg tablets in patients with liver disease appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Citihigh P 500mg/800mg Tablet :
Should you forget a Citihigh P 500mg/800mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citihigh P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
